A nurse is assessing a 10-year-old child with suspected von Willebrand's disease. Which assessment finding would be most characteristic of this condition?

Von Willebrand's disease is characterized by prolonged bleeding from mucosal surfaces and after procedures due to defective platelet adhesion and factor VIII deficiency.

Core Nursing Explanation Key Concept Analysis: This question assesses your ability to identify the characteristic clinical presentation of von Willebrand disease (vWD), the most common inherited bleeding disorder. The core pathophysiology involves a deficiency or dysfunction of von Willebrand factor (vWF). vWF has two critical roles: 1) It acts as a "glue" to help platelets adhere to damaged blood vessel walls, and 2) It serves as a carrier protein for clotting factor VIII, stabilizing it in the bloodstream. A defect in vWF leads to impaired primary hemostasis (the initial platelet plug formation) and secondary reduction in factor VIII levels.

Answer Rationale: Key Point! The hallmark of vWD is mucocutaneous bleeding. This includes prolonged bleeding from the gums, frequent nosebleeds (epistaxis), heavy menstrual bleeding (menorrhagia), and, as in the correct answer, prolonged bleeding after dental procedures or minor injuries. These are superficial injuries involving mucosal surfaces or skin, precisely where the platelet adhesion function of vWF is most crucial. This pattern is distinct from the deep tissue bleeding seen in disorders like hemophilia.

Distractor Analysis:
Watch out for confusion! Option ②, Petechiae scattered over the trunk and extremities, is more characteristic of disorders involving low platelet counts (thrombocytopenia) or platelet function defects where tiny capillaries leak. While vWD affects platelet function, petechiae are not its classic presentation.
Watch out for confusion! Option ③, Deep muscle hematomas without apparent trauma, and Option ④, Hemarthrosis in large joints such as knees and ankles, are the classic signs of Hemophilia A (Factor VIII deficiency) or Hemophilia B (Factor IX deficiency). These conditions affect the coagulation cascade more profoundly, leading to bleeding into deep tissues, muscles, and joints. Although vWD can cause a secondary decrease in Factor VIII, it rarely presents with severe spontaneous deep bleeding like hemophilia.

Related Concepts: Understanding the difference between disorders of primary hemostasis (platelet/vWF problems) and secondary hemostasis (coagulation factor problems) is essential. vWD straddles both but primarily presents as a primary hemostasis disorder. Laboratory findings include prolonged Bleeding Time (BT) and possibly prolonged Activated Partial Thromboplastin Time (aPTT), with a normal Prothrombin Time (PT).

Concept Summary

Disorder	Defective Component	Characteristic Bleeding Pattern	Key Lab Tests
Von Willebrand Disease	von Willebrand Factor (vWF)	Mucocutaneous: Nosebleeds, gum bleeding, heavy menses, prolonged bleeding after cuts/procedures.	↑ Bleeding Time, ↑ aPTT (sometimes), normal PT, specific vWF assays.
Hemophilia A	Factor VIII	Deep tissue: Joint bleeds (hemarthrosis), muscle hematomas, retroperitoneal bleeding.	↑↑ aPTT, normal PT & Bleeding Time.
Immune Thrombocytopenic Purpura (ITP)	Platelets (autoimmune destruction)	Superficial: Petechiae, purpura, mucosal bleeding (similar to vWD but with low platelet count).	↓ Platelet count, normal PT/aPTT/Bleeding Time (if platelets are functional).

Side-by-Side Comparison!

Feature	Von Willebrand Disease (vWD)	Hemophilia
Primary Defect	von Willebrand Factor (vWF)	Factor VIII (Hemophilia A) or IX (Hemophilia B)
Inheritance	Mostly Autosomal Dominant	X-linked Recessive
Bleeding Site	Mucous membranes, skin (superficial)	Joints, muscles, deep tissues
Onset of Bleeding	Immediate after injury	Delayed, may continue for days
Classic Presentation in a Child	Prolonged nosebleed, bleeding after losing a tooth	Swollen, painful knee after minor bump

Anatomy, Physiology & Pharmacology Points Physiology: Remember the "vWF Bridge" analogy. vWF forms a bridge between exposed collagen at a vessel injury site and platelet receptors (GP Ib). No bridge = poor platelet adhesion = unstable initial plug.
Pharmacology: First-line treatment for many types of vWD is Desmopressin (DDAVP). It stimulates the release of stored vWF and Factor VIII from endothelial cells. For more severe cases or when DDAVP is ineffective, von Willebrand Factor concentrates are used.

Memory Tips Mnemonic: "Von Willebrand is Very Wet" – Think of "wet" bleeding: nosebleeds, gum bleeding, heavy periods. It's on the surface.
Association: Hemophilia causes "Hard" bleeding – into hard structures like joints and deep muscles.

High-Frequency NCLEX Topics NCLEX loves to test your ability to differentiate between common bleeding disorders based on clinical presentation. Be ready to distinguish vWD (mucosal/superficial) from hemophilia (deep/joint) and from ITP/DIC (petechiae/purpura). Knowing the inheritance patterns is also a common question.

Watch Out for Question Variations! * Shift to Pharmacology: "The nurse is preparing to administer Desmopressin (DDAVP) to a child with vWD. Which outcome indicates the medication is effective?" * Shift to Patient Education: "Which instruction is most important for the nurse to include when teaching the parents of a child with vWD?" * Shift to Lab Interpretation: "The nurse reviews lab results for a child with frequent nosebleeds. Which finding is most suggestive of von Willebrand disease?" (You'd look for prolonged bleeding time).

Nursing Clinical Practice Guide Clinical Scenario: You are a pediatric nurse. A 10-year-old boy is brought to the clinic by his mother, who reports he has had a nosebleed that lasted over 30 minutes and that his gums bleed easily when he brushes his teeth. He recently had a baby tooth fall out, and it oozed blood intermittently for two days. There is a family history of "easy bleeding" on his mother's side.

Nursing Intervention Strategy: 1. Assessment: Conduct a thorough bleeding history using a tool like the ISTH-BAT (Bleeding Assessment Tool). Document frequency, duration, and triggers of bleeding episodes (spontaneous vs. post-injury/procedure). Perform a physical exam, looking for signs of anemia (pallor, fatigue) and checking for any active bleeding or old bruising. 2. Nursing Diagnosis & Planning: Risk for Injury (bleeding) related to impaired clotting mechanism. The plan includes preventing injury and managing active bleeding episodes. 3. Implementation: * Preventive Care: Educate the child and family to use a soft-bristle toothbrush, avoid contact sports or activities with high impact risk, and use protective gear. Ensure all healthcare providers are aware of the diagnosis before any procedures. * Acute Bleeding Management: For a nosebleed (epistaxis), instruct to sit upright, lean forward slightly, and apply direct, continuous pressure to the soft part of the nose for at least 10-15 minutes. Apply ice to the bridge of the nose. * Medication Administration: If prescribed Desmopressin (DDAVP), administer as ordered, typically intranasally or IV. Monitor for side effects like fluid retention, hyponatremia, and headache. 4. Evaluation: Evaluate for a reduction in frequency/severity of bleeding episodes. Monitor for signs of anemia and ensure the family can demonstrate proper first-aid for minor bleeds.

Patient Safety and Precautions: * Medication Alert: Patients with vWD must AVOID medications that impair platelet function, such as aspirin, NSAIDs (e.g., ibuprofen, naproxen), and other antiplatelet drugs, as they can significantly increase bleeding risk. * Procedure Precautions: Prior to surgeries or dental work, a hematology consult is essential. Prophylactic treatment with DDAVP or vWF concentrate may be required.

Nursing Procedure & Medication Flow Administering Desmopressin (DDAVP) - Intranasal Route: 1. Verify order, patient, and medication. Check baseline vital signs and serum sodium if available. 2. Have the patient blow their nose gently to clear passages. 3. Insert the tip of the nasal spray bottle into one nostril. Have the patient hold the other nostril closed and breathe in gently while you spray. 4. Document the administration, dose, and nostril used. 5. Monitor: Watch for therapeutic effect (controlled bleeding). Monitor for adverse effects: assess for signs of hyponatremia (headache, nausea, confusion, seizures), fluid overload (weight gain, edema), and hypertension. Fluid intake may be restricted for 1 hour before and 8 hours after dose to prevent hyponatremia.

A Word from Your Senior Nurse "Pediatric bleeding disorders require a delicate balance. We want kids to be kids, but we also must be their advocates for safety. When you see that history of 'easy bruising' or 'long nosebleeds,' dig deeper. Connecting the dots between family history, symptom pattern, and pathophysiology is what makes an excellent nurse. In clinicals and on the NCLEX, always ask yourself: 'Is this bleeding superficial or deep?' That one question will often lead you straight to the correct disorder and the priority nursing action."